China’s CanSino Biologics has 16 vaccine candidates in the pipeline, including Covid-19 and meningitis. Photo: Reuters
Pfizer endorses CanSino’s meningitis vaccine, giving Chinese biotech company a shot in the arm
- US global pharmaceutical giant Pfizer will promote Hong Kong-listed CanSino Biologics’ Menhycia meningitis vaccine candidate in the mainland
- China National Medical Products Administration put the vaccine on the fast track list in December, but has yet to approve it
Follow your favourite topic and get notified
China’s CanSino Biologics has 16 vaccine candidates in the pipeline, including Covid-19 and meningitis. Photo: Reuters